0001493152-24-033271.txt : 20240820
0001493152-24-033271.hdr.sgml : 20240820
20240820161755
ACCESSION NUMBER: 0001493152-24-033271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240816
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tempus AI, Inc.
CENTRAL INDEX KEY: 0001717115
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
ORGANIZATION NAME: 06 Technology
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38943
FILM NUMBER: 241225349
BUSINESS ADDRESS:
STREET 1: 600 WEST CHICAGO AVENUE
STREET 2: SUITE 510
CITY: CHICAGO
STATE: IL
ZIP: 60654
BUSINESS PHONE: 800-976-5448
MAIL ADDRESS:
STREET 1: 600 WEST CHICAGO AVENUE
STREET 2: SUITE 510
CITY: CHICAGO
STATE: IL
ZIP: 60654
FORMER NAME:
FORMER CONFORMED NAME: Tempus Labs, Inc.
DATE OF NAME CHANGE: 20170915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Personalis, Inc.
CENTRAL INDEX KEY: 0001527753
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 275411038
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6600 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 650-752-1300
MAIL ADDRESS:
STREET 1: 6600 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
4
1
ownership.xml
X0508
4
2024-08-16
0
0001527753
Personalis, Inc.
PSNL
0001717115
Tempus AI, Inc.
600 WEST CHICAGO AVENUE
SUITE 510
CHICAGO,
IL
60654
0
0
1
0
0
Common Stock
2024-08-16
4
X
0
4609400
1.50
A
4609400
D
Common Stock
2024-08-16
4
X
0
4609400
2.50
A
9218800
D
Common Stock
2024-08-16
4
P
0
3500000
5.07
A
12718800
D
Warrant (Right to Buy)
1.50
2024-08-16
4
X
0
4609400
D
2023-11-28
2024-12-31
Common Stock
4609400
0
D
Warrant (Right to Buy)
2.50
2024-08-16
4
X
0
4609400
D
2023-11-28
2025-12-31
Common Stock
4609400
0
D
The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person.
Tempus AI, Inc. By: /s/ Andrew Polovin, General Counsel
2024-08-20